Glutaredoxin and Thioredoxin enzyme levels in endometrial fluid obtained from pregnant women after in vitro fertilization (IVF) treatment compared with non-pregnant women

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20211006003

Enrollment

Registered

2021-10-06

Start date

2021-02-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glutaredoxin and Thioredoxin enzyme levels in endometrial fluid obtained from women undergoing in vitro fertilization (IVF) treatment glutaredoxin, thioredoxin, pinopodes, oxidative stress, in vitro fertilization, endometrial receptivity, window of implantation, endometrial fluid

Interventions

- Age 25-42 years old - No endometriotic cyst, no myoma that distort uterine cavity, no hydrosalpinx, no STD

Basic Science

Infertile women

Eligibility

Sex/Gender

Female

Age

25 Years to 42 Years

Inclusion criteria

Inclusion criteria: Infertile female who have undergone treatment at IVF unit, Chulalongkorn Hospital and will transfer good quality cryopreserved embryo day 5

Exclusion criteria

Exclusion criteria: Who have hydrosalpinx, endometriotic cyst, sexual transmitted diseases, hyperprolactinemia, poor-controlled diabetes, hyper/hypothyroid

Design outcomes

Primary

Measure	Time frame
Glutaredoxin and Thioredoxin enzyme levels in endometrial fluid compared between pregnant and non-pregnant group 1 month ELISA	—

Secondary

Measure	Time frame
Glutaredoxin compared to thioredoxin 1 month ELISA	—

Countries

Thailand

Contacts

Public ContactThanisa Kitjaras

King Chulalongkorn Memorial Hospital

nanviesz@gmail.com0906644925

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026